Expertises

Fetal medicine; screening for fetal chromosomal abnormalities; preterm delivery; intrauterine growth retardation; medical education

Main research areas

Screening for fetal chromosome abnormalities in the first trimester of pregnancy, using combined first trimester risk assessment, and/or cell-free fetal DNA analysis.

Prediction of pretem delivery using assessment of cervical length.

Prevention of preterm delivery.

Long-term follow up after detection of increased nuchal translucency or structural anormalies in the first and second trimester of pregnancy.

Intrauterine growth retardation.

Physical wellbeing in pregnancy.

Current research

Prediction of preterm delivery by cervical length assessment, in the general population and in high-risk groups.

Detection of Trisomy 21 using the current first trimester risk assessment, in comparison to cfDNA testing.

Follow-up of infants detected with ventriculomegaly at second trimester ultrasound scan.

Assessment of fetal blood flow using ultrasound and MRI.

Complications in monochorionic pregnancies.

WHO study on Intrauterine growth in normal pregnancies.

Low back pain in pregnancy: RCT on the effect of water training.

Potential conflicts of interest

Ariosa-Roche have performed cfDNA tests in two studies, at cost price.